Xeris Biopharma Reports Second Quarter 2026 Financial Results

Go back to Xeris Biopharma Reports Second Quarter 2026 Financial Results
(NASDAQ: XERS) Delayed: 8.28 +0.29 (3.63%)
Previous Close $7.99    52 Week High
Open $8.00    52 Week Low
Day High $8.29    P/E N/A 
Day Low $7.96    EPS
Volume 697,306